Blue Jet Healthcare Limited (NSE:BLUEJET)

Blue Jet Healthcare Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Blue Jet Healthcare stock has a consensus rating of "Buy" and an average price target of ₹501.00. The average 1-year stock price forecast is 13.31% higher than the current stock price, while the lowest is ₹370.00 (-16.32%) and the highest is ₹600.00 (+35.70%).

Price Target: ₹501.00 (+13.31%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	₹370.00	₹501.00	₹505.00	₹600.00
Change	-16.32%	+13.31%	+14.21%	+35.70%

Analyst Ratings

The average analyst rating for Blue Jet Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Apr '26
Strong Buy	4	4	4	4	3	3
Buy	0	0	0	0	1	1
Hold	2	1	1	1	0	0
Sell	0	1	1	1	2	2
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	6

Financial Forecast

Revenue This Year

11.66B

Increased by 23.05%

from 9.47B

Revenue Next Year

14.56B

Increased by 24.95%

from 11.66B

EPS This Year

17.25

Increased by 20.73%

from 14.29

EPS Next Year

19.14

Increased by 10.97%

from 17.25

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	6.83B	7.21B	7.12B	10.30B	9.47B	11.66B
Revenue Growth	36.99%	5.49%	-1.30%	44.74%	-8.03%	23.05%
Gross Profit	3.89B	3.78B	3.90B	5.61B	5.12B	6.28B
Gross Margin	56.89%	52.47%	54.86%	54.42%	54.00%	53.86%
Operating Income	2.28B	1.94B	2.01B	3.60B	2.70B	3.44B
Net Income	1.82B	1.60B	1.64B	3.05B	2.48B	2.99B
EPS	10.47	9.23	9.44	17.59	14.29	17.25
EPS Growth	31.19%	-11.88%	2.33%	86.34%	-18.76%	20.73%
Forward PE	-	-	-	48.10	20.98	25.63
Dividend / Share	-	-	1.00	1.20	1.20	1.53
Dividend Growth	-	-	-	20.00%	-	27.60%
Free Cash Flow	833.57M	567.80M	267.62M	-1.13B	795.49M	-1.09B
No. Analysts	-	-	-	-	-	5

Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	12.4B
Avg	11.7B
Low	11.0B

Revenue Growth

Revenue Growth	2027	2028	2029
High	30.6%
Avg	23.0%
Low	16.4%

EPS Forecast

EPS	2027	2028	2029
High	18.80
Avg	17.25
Low	16.30

EPS Growth

EPS Growth	2027	2028	2029
High	31.6%
Avg	20.7%
Low	14.1%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.